Prostaglandin production by melanocytic cells and the effect of α-melanocyte stimulating hormone

FEBS Letters

Volumn 570, Issue 1-3, 2004, Pages 223-226

  Nicolaou, Anna ^a   Estdale, Sian E ^a   Tsatmali, Marina ^a   Herrero, Daniel Pascual ^a   Thody, Anthony J ^a,b  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Melanocyte stimulating hormone; MSH, melanocyte stimulating hormone; COX, cyclooxygenase; Cyclooxygenase; FM55; HaCaT; Melanocytic cell; Prostaglandin

Indexed keywords

ALPHA INTERMEDIN; ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; INDOMETACIN; PROSTAGLANDIN; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL LINE; CONTROLLED STUDY; HUMAN; HUMAN CELL; KERATINOCYTE; MELANOCYTE; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALPHA-MSH; CELL LINE; CELL SURVIVAL; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; HUMANS; INFLAMMATION; ISOENZYMES; KERATINOCYTES; MELANOCYTES; MEMBRANE PROTEINS; PHENOTYPE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 3142576701     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2004.06.041     Document Type: Article

References (25)

1. Nicolaou, A. (2004) in: Nicolaou, A., Kokotos, G., (Eds.), Bioactive Lipids, Oily Press. (in press)
2. Smith K.J., Skelton H. J. Cutan. Med. Surg. 6:2002;241-256
3. Tsatmali M., Ancans J., Thody A.J. J. Histochem. Cytochem. 50:2002;125-133
4. Goulet A.C., et al. Cancer Biol. Ther. 2:2003;713-718
5. Denkert C., Kobel M., Berger S., Siegert A., Leclere A., Trefzer U., Hauptmann S. Cancer Res. 61:2001;303-308
6. Higashi Y., Kanekura T., Kanzaki T. Int. J. Cancer. 86:2000;667-671
7. Bishop-Bailey D., Calatayud S., Warner T.D., Hla T., Mitchell J.A. J. Environ. Pathol. Toxicol. Oncol. 21:2002;93-101
8. Slominski A., Wortsman J., Luger T., Paus R., Solomon S. Physiol. Rev. 80:2000;979-1020
9. Kadekaro A.L., Kanto H., Kavanagh R., Abdel-Malek Z.A. Ann. NY Acad. Sci. 994:2003;359-365
10. Eves P., et al. Br. J. Cancer. 89:2003;2004-2015
11. Tsatmali M., Graham A., Szatkowski D., Ancans J., Manning P., McNeil C.J., Graham A.M., Thody A.J. J. Invest. Dermatol. 114:2000;520-526
12. Luger T.A., Scholzen T.E., Brzoska T., Bohm M. Ann. NY Acad. Sci. 994:2003;133-140
13. Hunt G., Thody A.J. Cell and Tissue Culture: Laboratory Procedures. 1994;Wiley, Chistester. Chapter 11
14. Urquhart P., Parkin S.M., Rogers J.S., Bosley J.A., Nicolaou A. Biochim. Biophys. Acta. 28:2002;2-3
15. Buckman S.Y., Gresham A., Hale P., Hruza G., Anast J., Masferrer J., Pentland A.P. Carcinogenesis. 19:1998;723-729
16. Bachelor M.A., Silvers A.L., Bowden G.T. Oncogene. 21:2002;7092-7099
17. Hedley S.J., Gawkrodger D.J., Weetman A.P., Morandini R., Boeynaems J.M., Ghanem G., Neil S.M. Br. J. Dermatol. 138:1998;536-543
18. Stjernschantz J.W., Albert D.M., Hu D.N., Drago F., Wistrand P.J. Surv. Ophthalmol. 47:2002;S162-S175
19. Tomita Y., Maeda K., Tagami H. Pigm. Cell. Res. 5:1992;357-361
20. Grewe M., Trefzer U., Ballhorn A., Gyufko K., Henninger H., Krutmann J. J. Invest. Dermatol. 101:1993;528-531
21. Shiratori K., Ohgami K., Ilieva I.B., Koyama Y., Yoshida K., Ohno S. Invest. Ophthalmol. Vis. Sci. 45:2004;159-164
22. Haycock J.W., Rowe S.J., Cartledge S., Wyatt A., Ghanem G., Morandini R., Rennie I.G., MacNeil S. J. Biol. Chem. 275:2000;15629-15636
23. Moustafa M., Szabo M., Ghanem G.E., Morandini R., Kemp E.H., MacNeil S., Haycock J.W. J. Invest. Dermatol. 119:2002;1244-1253
24. Rhodes L.E., Belgi G., Parslew R., McLoughlin L., Clough G.F., Friedmann P.S. J. Invest. Dermatol. 117:2001;880-885
25. Matsumura Y., Ananthaswamy H.N. Expert Rev. Mol. Med. 2:2002;1-22